In an interview with VentureBeat, Bioptimus CEO Jean-Philippe Vert stated that as a smaller, independent company, Bioptimus can move faster than Google DeepMind to gain direct access to the data needed to train biology models. The company's work will be released as open source/open science, with a focus on transparency, sharing, and community. The biggest challenge, according to Vert, is access to data, which Bioptimus has through its partnership with Owkin.
Key takeaways:
- Paris-based startup Bioptimus, aiming to build the first universal AI foundation model for biology, has emerged from stealth with a seed funding round of $35 million.
- Bioptimus is uniting a team of Google DeepMind alumni and Owkin scientists to leverage AWS compute and Owkin’s data generation capabilities and access to multimodal patient data sourced from leading academic hospitals worldwide.
- According to Bioptimus CEO Jean-Philippe Vert, the company can move faster than Google DeepMind to gain direct access to the data needed to train biology models due to its smaller size and independence.
- The work of Bioptimus will be released as open source/open science, with a focus on transparency, sharing, and community.